Mana Hatanaka

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

National Institute of Infectious Diseases(Current)

Mana Hatanaka is an author at National Institute of Infectious Diseases specializing in non-small cell lung cancer treatment, tumor resistance, and egfr inhibition.

ORCID

Publications per year

2019–2022

Publications

DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model

Takeshi Jimbo, Mana Hatanaka, Takahiro Komatsu et al. · Oncotarget · 2019 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

Relationship between intra-individual variability in nutrition-related lifestyle behaviors and blood glucose outcomes under free-living conditions in adults without type 2 diabetes

Eiichi Yoshimura, Yuka Hamada, Mana Hatanaka et al. · Diabetes Research and Clinical Practice · 2022 · 11 citations · Full text

Medicine, Nutrition, Nutritional Sciences +13

1–2 of 2